ArticleCureus2026

Extended Intrapleural Tissue Plasminogen Activator (tPA)-Dornase Alfa (DNase) Therapy Beyond the Standard Multicenter Intrapleural Sepsis Trial 2 (MIST-2) Regimen in a High-Risk Patient With Complex Empyema: A Case Report.

Rodrigo Furlan Silva Fabri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.